A review on potential therapeutic properties of Pomegranate (Punica granatum L.)
DOI:
https://doi.org/10.14719/pst.2020.7.1.619Keywords:
Anticancer, Antioxidant, Cytoprotective, TherapeuticAbstract
Pomegranate (Punica granatum L. formerly in Punicaceae family) considered to be super food worldwide, belongs to the family Lythraceae. It is primarily cultivated in the Middle East, north and tropical Africa, the Indian subcontinent, Asia and Latin America. The medicinal potential of pomegranate is extensively mentioned in the ancient literature and also used in different system of medicines for a variety of ailments. The chemical constituents of pomegranate have increased the research concern of this fruit in the current years. It includes a variety of bioactive compounds such as quercetin, ellagic acid, punicalagin, pedunculagin, tannic acid, anthocyanins, rutin, catechin and polyphenols. These components of pomegranate possess antioxidant, neuroprotective, anti-inflammatory, anti-angiogenic, anticancerous, anti-mutagenic, cytoprotective, cardiovascular protective, anti-diabetic, anti-ulcerogenic, hepatoprotective, antibacterial and antifungal potentials. It can enhance the male fertility and also protect from the UV induced skin damage. Furthermore, it also illustrate the inhibitory effects on vital metabolic enzymes, stimulate cell differentiation and toxicological properties. The pomegranate also impedes with numerous signalling pathways, which include Bax, Bcl-X, Bad, ERK1/2, JNK, PI3K/AKT, mTOR, PI3K, MAPK and P38. The present review will extensively discuss the above properties of pomegranate and its extracts, supporting the rich nutritive and healthy advantages of the fruit belonging to the monogeneric family.
Downloads
Download data is not yet available.
References
1. Facciola S. Cornucopia: a source book of edible plants. Kampong publications; 1990.
2. Borochov-Neori H, Judeinstein S, Harari M, Bar-Ya’akov I, Patil BS, Lurie S, et al. Climate effects on anthocyanin accumulation and composition in the pomegranate (Punica granatum L.) fruit arils. J Agric Food Chem. 2011;3;59(10):5325-34. https://doi.org/10.1021/jf2003688
3. Andrés AI, Petrón MJ, Adámez JD, López M, Timón ML. Food by-products as potential antioxidant and antimicrobial additives in chill stored raw lamb patties. Meat Sci. 2017;1;129:62-70. https://doi.org/10.1016/j.meatsci.2017.02.013
4. Rahimi HR, Arastoo M, Ostad SN. A comprehensive review of Punica granatum (pomegranate) properties in toxicological, pharmacological, cellular and molecular biology researches. Iran J Pharm Res.2012;11(2):385.
5. Stover ED, Mercure EW. The pomegranate: a new look at the fruit of paradise. Hort Science. 2007;1;42(5):1088-92. https://doi.org/10.21273/HORTSCI.42.5.1088
6. Dahlgren R, Thorne RF. The order Myrtales: circumscription, variation, and relationships. Ann Mo Bot Gard. 1984 Jan 1:633-99. https://doi.org/10.2307/2399158
7. Jurenka J. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev. 2008;1;13(2).
8. Naqvi S, Khan MS, Vohora SB. Anti-bacterial, anti-fungal and anthelmintic investigations on Indian medicinal plants. Fitoterapia. 1991;62(3):221-8.
9. Cáceres A, Girón LM, Alvarado SR, Torres MF. Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases. J Ethnopharmacol. 1987;1;20(3):223-37. https://doi.org/10.1016/0378-8741(87)90050-X
10. Lad V, Frawley D. The Yoga of Herbs. Santa Fe. 1986;135-36.
11. Saxena A, Vikram NK. Role of selected Indian plants in management of type 2 diabetes: a review. J. Altern. Complementary Med. 2004;1;10(2):369-78. https://doi.org/10.1089/107555304323062365
12. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;19;109(2):177-206. https://doi.org/10.1016/j.jep.2006.09.006
13. Derakhshan Z, Ferrante M, Tadi M, Ansari F, Heydari A, Hosseini MS, et al. Antioxidant activity and total phenolic content of ethanolic extract of pomegranate peels, juice and seeds. Food Chem Toxicol. 2018;1;114:108-11.https://doi.org/10.1016/j.fct.2018.02.023
14. Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food chem. 2006; 1;96(2):254-60. https://doi.org/10.1016/j.foodchem.2005.02.033
15. Mandal A, Bhatia D, Bishayee A. Anti-inflammatory mechanism involved in pomegranate-mediated prevention of breast cancer: The role of NF-?B and Nrf2 signaling pathways. Nutrients. 2017;9(5):436. https://doi.org/10.3390/nu9050436
16. Rouhi SZ, Sarker MM, Rahmat A, Alkahtani SA, Othman F. The effect of pomegranate fresh juice versus pomegranate seed powder on metabolic indices, lipid profile, inflammatory biomarkers, and the histopathology of pancreatic islets of Langerhans in streptozotocin-nicotinamide induced type 2 diabetic Sprague–Dawley rats. BMC Complement Altern Med. 2017;17(1):156. https://doi.org/10.1186/s12906-017-1724-1
17. Braidy N, Selvaraju S, Essa MM, Vaishnav R, Al-Adawi S, Al-Asmi A, et al. Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons. Oxid Med Cell Longev. 2013;3;2013. https://doi.org/10.1155/2013/685909
18. Rahmani AH, Alsahli MA, Almatroodi SA. Active constituents of pomegranates (Punica granatum) as potential candidates in the management of health through modulation of biological activities. PhcogJ. 2017;9(5). https://doi.org/10.5530/pj.2017.5.109
19. Moghaddam G, Sharifzadeh M, Hassanzadeh G, Khanavi M, Hajimahmoodi M. Anti-ulcerogenic activity of the pomegranate peel (Punica granatum) methanol extract. Food Nutr Sci. 2013; 12;4(10):43. https://doi.org/10.4236/fns.2013.410A008
20. Amri Z, Ghorbel A, Turki M, Akrout FM, Ayadi F, Elfeki A, Hammami M. Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model. BMC Complement Altern Med. 2017;17(1):339. https://doi.org/10.1186/s12906-017-1842-9
21. Razani Z, Dastani M, Kazerani HR. Cardioprotective effects of pomegranate (Punica granatum) juice in patients with ischemic heart disease. Phytother Res. 2017;31(11):1731-8. https://doi.org/10.1002/ptr.5901
22. Forest CP, Padma-Nathan H, Liker HR. Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study. Int J Impot Res. 2007;19(6):564. https://doi.org/10.1038/sj.ijir.3901570
23. Rahmani AH, Alsahli MA, Almatroodi SA. Active constituents of pomegranates (Punica granatum) as potential candidates in the management of health through modulation of biological activities. PhcogJ. 2017;9(5). https://doi.org/10.5530/pj.2017.5.109
24. Sastravaha G, Gassmann G, Sangtherapitikul P, Grimm WD. Adjunctive periodontal treatment with Centella asiatica and Punica granatum extracts in supportive periodontal therapy. J Int Acad Periodontol. 2005;7(3):70-79.
25. Kim YH, Choi EM. Stimulation of osteoblastic differentiation and inhibition of interleukin?6 and nitric oxide in MC3T3?E1 cells by pomegranate ethanol extract. Phytother Res. 2009;23(5):737-39. https://doi.org/10.1002/ptr.2587
26. Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 2006;1;24(3):506-15. https://doi.org/10.1016/j.nbd.2006.08.006
27. Afaq F, Zaid MA, Khan N, Dreher M, Mukhtar H. Protective effect of pomegranate?derived products on UVB?mediated damage in human reconstituted skin. Exp Dermatol. 2009;18(6):553-61. https://doi.org/10.1111/j.1600-0625.2008.00829.x
28. Sreekumar S, Sithul H, Muraleedharan P, Azeez JM, Sreeharshan S. Pomegranate fruit as a rich source of biologically active compounds. BioMed Res. Int. 2014. https://doi.org/10.1155/2014/686921
29. Viuda?Martos M, Fernández?López J, Pérez?Álvarez JA. Pomegranate and its many functional components as related to human health: a review. Compr Rev Food Sci Food Saf. 2010;9(6):635-54. https://doi.org/10.1111/j.1541-4337.2010.00131.x
30. Hernandez F, Melgarejo P, Tomas-Barberan FA, Artes F. Evolution of juice anthocyanins during ripening of new selected pomegranate (Punica granatum) clones. Eur Food Res Technol. 1999;1;210(1):39-42. https://doi.org/10.1007/s002170050529
31. Nasr CB, Ayed N, Metche M. Quantitative determination of the polyphenolic content of pomegranate peel. Eur Food Res Technol. 1996;1;203(4):374-8. https://doi.org/10.1007/BF01231077
32. Singh B, Singh JP, Kaur A, Singh N. Phenolic compounds as beneficial phytochemicals in pomegranate (Punica granatum L.) peel: A review. Food chem. 2018; 30;261:75-86. https://doi.org/10.1016/j.foodchem.2018.04.039
33. Kalayc?o?lu Z, Erim FB. Total phenolic contents, antioxidant activities, and bioactive ingredients of juices from pomegranate cultivars worldwide. Food chem. 2017; 15;221:496-507. https://doi.org/10.1016/j.foodchem.2016.10.084
34. Fadavi A, Barzegar M, Azizi MH. Determination of fatty acids and total lipid content in oilseed of 25 pomegranates varieties grown in Iran.
J Food Compost Anal. 2006;1;19(6-7):676-80. https://doi.org/10.1016/j.jfca.2004.09.002
35. Du CT, Wang PL, Francis FJ. Anthocyanins of pomegranate, Punica granatum. J. Food Sci. 1975;40(2):417-18. https://doi.org/10.1111/j.1365-2621.1975.tb02217.x
36. http://www.nutritiondata.com/facts-C00001-01c20Ws.html. Nutrition data for pomegranate [accessed May 2015].
37. Amakura Y, Okada M, Tsuji S, Tonogai Y. Determination of phenolic acids in fruit juices by isocratic column liquid chromatography. J Chromatogr A. 2000; 1;891(1):183-8. https://doi.org/10.1016/S0021-9673(00)00625-7
38. de Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J Agric Food Chem. 2000; 20;48(11):5331-7. https://doi.org/10.1021/jf000549h
39. Artik N. Determination of phenolic compounds in pomegranate juice by using HPLC. Fruit Processing. 1998;8:492-9.
40. Waheed S, Siddique N, Rahman A, Zaidi JH, Ahmad S. INAA for dietary assessment of essential and other trace elements in fourteen fruits harvested and consumed in Pakistan. J Radioanal Nucl Chem. 2004;1;260(3):523-31. https://doi.org/10.1023/B:JRNC.0000028211.23625.99
41. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. Journal J Ethnopharmacol. 1999;1;66(1):11-7. https://doi.org/10.1016/S0378-8741(98)00222-0
42. Abd El Wahab SM, El Fiki NM, Mostafa SF, et al. Characterization of certain steroid hormones in Punica granatum L. seeds. Bull Fac Pharm 1998;36:11-15.
43. Tanaka T, Nonaka GI, Nishioka I. Tannins and Related Compounds. XL.: Revision of the Structures of Punicalin and Punicalagin, and Isolation and Characterization of 2-O-Galloylpunicalin from the Bark of Punica granatum L. Chem Pharm Bull. 1986;25;34(2):650-55. https://doi.org/10.1248/cpb.34.650
44. Nawwar MA, Hussein SA, Merfort I. NMR spectral analysis of polyphenols from Punicagranatum.Phytochemistry. 1994;1;36(3):793-98. https://doi.org/10.1016/S0031-9422(00)89820-9
45. Noda Y, Kaneyuki T, Mori A, Packer L. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric Food Chem. 2002; 2;50(1):166-71. https://doi.org/10.1021/jf0108765
46. Huang TH, Yang Q, Harada M, Li GQ, Yamahara J, Roufogalis BD, et al. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J Cardiovasc Pharmacol.2005;1;46(6):856-62. https://doi.org/10.1097/01.fjc.0000190489.85058.7e
47. Batta AK, Rangaswami S. Crystalline chemical components of some vegetable drugs. Phytochemistry. 1973.
48. Neuhöfer H, Witte L, Gorunovic M, Czygan FC. Alkaloids in the bark of Punica granatum L. (pomegranate) from Yugoslavia. Pharmazie. 1993;48(5):389-91.
49. Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G. Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Eur Urol. 2005; 1;47(4):449-55. https://doi.org/10.1016/j.eururo.2004.12.001
50. Hassoun EA, Vodhanel J, Abushaban A. The modulatory effects of ellagic acid and vitamin E succinate on TCDD?induced oxidative stress in different brain regions of rats after subchronic exposure. J Biochem Mol Toxicol. 2004;18(4):196-203. https://doi.org/10.1002/jbt.20030
51. Mertens-Talcott SU, Bomser JA, Romero C, Talcott ST, Percival SS. Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr. 2005; 1;135(3):609-14. https://doi.org/10.1093/jn/135.3.609
52. Mertens-Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 2005;10;218(2):141-51. https://doi.org/10.1016/j.canlet.2004.06.007
53. Lansky EP, Jiang W, Mo H, Bravo L, Froom P, Yu W, et al. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs.2005;1;23(1):11-20. https://doi.org/10.1023/B:DRUG.0000047101.02178.07
54. Lansky EP, Harrison G, Froom P, Jiang WG. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel™. Invest New Drugs. 2005;1;23(2):121-2. https://doi.org/10.1007/s10637-005-5856-7
55. Seeram NP, Lee R, Heber D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta. 2004; 1;348(1-2):63-8. https://doi.org/10.1016/j.cccn.2004.04.029
56. Cerdá B, Espín JC, Parra S, Martínez P, Tomás-Barberán FA. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6–one derivatives by the colonic microflora of healthy humans. Eur J Nutr. 2004;1;43(4):205-20. https://doi.org/10.1007/s00394-004-0461-7
57. Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci. 2005;13;102(37):13254-9. https://doi.org/10.1073/pnas.0504830102
58. Wekerle H. Brain autoimmunity and intestinal microbiota: 100 trillion game changers. Trends Immunol. 2017;1;38(7):483-97.https://doi.org/10.1016/j.it.2017.03.008
59. Gibson GR. Prebiotics as gut microflora management tools. J Clin Gastroenterol.2008;1;42:S75-9. https://doi.org/10.1097/MCG.0b013e31815ed097
60. Rastall RA, Gibson GR, Gill HS, Guarner F, Klaenhammer TR, Pot B, et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications.FEMS MicrobiolEcol.2005;1;52(2):145-52. https://doi.org/10.1016/j.femsec.2005.01.003
61. Bialonska D, Ramnani P, Kasimsetty SG, Muntha KR, Gibson GR, Ferreira D. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int J Food Microbiol. 2010; 15;140(2-3):175-82. https://doi.org/10.1016/j.ijfoodmicro.2010.03.038
62. Bialonska D, Kasimsetty SG, Schrader KK, Ferreira D. The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria.JAgric Food Chem.2009;25;57(18):8344-9. https://doi.org/10.1021/jf901931b
63. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;1;20(5):649-88. https://doi.org/10.1210/edrv.20.5.0380
64. Han L, Shen WJ, Bittner S, Kraemer FB, Azhar S. PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-?. Future Cardiol. 2017;13(3):259-78. https://doi.org/10.2217/fca-2016-0059
65. Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, et al. A novel PPAR? gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology. 2003;1;124(5):1315-24. https://doi.org/10.1016/S0016-5085(03)00262-2
66. Ogata T, Miyauchi T, Sakai S, Irukayama-Tomobe Y, Katsutoshi GO, Yamaguchi I. Stimulation of peroxisome-proliferator-activated receptor ? (PPAR ?) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin Sci (Lond). 2002:284S-288S. https://doi.org/10.1042/CS103S284S
67. Hsu SC, Huang CJ. Changes in liver PPAR? mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice. J Nutr Biochem. 2007;1;18(2):86-96. https://doi.org/10.1016/j.jnutbio.2006.03.003
68. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, et al. PPAR-? and PPAR-? activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature medicine. 2001;7(1):53. https://doi.org/10.1038/83348
69. Bassaganya-Riera J, Guri AJ, Hontecillas R. Treatment of obesity-related complications with novel classes of naturally occurring PPAR agonists. J obes. 2010;28;2011. https://doi.org/10.1155/2011/897894
70. Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008;1;134(3):688-95. https://doi.org/10.1053/j.gastro.2007.12.012
71. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes care. 2004; 1;27(1):256-63. https://doi.org/10.2337/diacare.27.1.256
72. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.JAgric Food Chem.2000;16;48(10):4581-9. https://doi.org/10.1021/jf000404a
73. Rosenblat M, Volkova N, Coleman R, Aviram M. Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein. Journal J Agric Food Chem. 2006;8;54(5):1928-35. https://doi.org/10.1021/jf0528207
74. Guo C, Wei J, Yang J, Xu J, Pang W, Jiang Y. Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects. Nutr Res. 2008;1;28(2):72-77. https://doi.org/10.1016/j.nutres.2007.12.001
75. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol. 1999; 1;66(1):11-17. https://doi.org/10.1016/S0378-8741(98)00222-0
76. Chidambara Murthy KN, Jayaprakasha GK, Singh RP. Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models. Journal J Agric Food Chem. 2002; 14;50(17):4791-95. https://doi.org/10.1021/jf0255735
77. Viladomiu M, Hontecillas R, Lu P, Bassaganya-Riera J. Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evid Based Complement Alternat Med. 2013.. https://doi.org/10.1155/2013/789764
78. Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM, Patel A, et al. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food. 2004;1;7(3):274-83. https://doi.org/10.1089/jmf.2004.7.274
79. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci. 2005; 11;102(41):14813-18. https://doi.org/10.1073/pnas.0505870102
80. Sheu ML, Chao KF, Sung YJ, Lin WW, Lin-Shiau SY, Liu SH. Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cell Signal. 2005;1;17(8):975-84. https://doi.org/10.1016/j.cellsig.2004.11.015
81. Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, et al. Regulation of Cyclooxygenase-2 by Interferon ? and Transforming Growth Factor ? in Normal Human Epidermal Keratinocytes and Squamous Carcinoma Cells Role of mitogen-activated protein kinases. J. Biol. Chem. 1999;8;274(41):29138-48. https://doi.org/10.1074/jbc.274.41.29138
82. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007; 19;109(2):177-206. https://doi.org/10.1016/j.jep.2006.09.006
83. Okamoto T, Akuta T, Tamura F, van Der Vliet A, Akaike T. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol chem. 2004;1;385(11):997-1006. https://doi.org/10.1515/BC.2004.130
84. Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer lett. 2008; 8;269(2):262-8. https://doi.org/10.1016/j.canlet.2008.03.043
85. Conner EM, Grisham MB, “Inflammation, free radicals and antioxidants,” Nutrition, 1996;12(4): 274–7. https://doi.org/10.1016/S0899-9007(96)00000-8
86. Larrosa M, González-Sarrías A, Yáñez-Gascón MJ, Selma MV, Azorín-Ortuño M, Toti S, et al. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.JNutrBiochem.2010;1;21(8):717-25. https://doi.org/10.1016/j.jnutbio.2009.04.012
87. Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T, “Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats,” Cancer Sci. 2004;95(6):481-6. https://doi.org/10.1111/j.1349-7006.2004.tb03236.x
88. Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin. Cancer Res. 2006;12:4018-26. https://doi.org/10.1158/1078-0432.CCR-05-2290
89. Lansky EP, inventor; Lansky, Ephraim Philip, assignee. Phytoestrogen supplements prepared from pomegranate material including pomegranate seeds. United States patent US 6,060,063. 2000..
90. Lansky EP, inventor; Lansky, Ephraim Philip, assignee. Phytoestrogen supplement prepared from pomegranate seeds and a herbal mixture or coconut milk. United States patent US 5,891,440. 1999.
2. Borochov-Neori H, Judeinstein S, Harari M, Bar-Ya’akov I, Patil BS, Lurie S, et al. Climate effects on anthocyanin accumulation and composition in the pomegranate (Punica granatum L.) fruit arils. J Agric Food Chem. 2011;3;59(10):5325-34. https://doi.org/10.1021/jf2003688
3. Andrés AI, Petrón MJ, Adámez JD, López M, Timón ML. Food by-products as potential antioxidant and antimicrobial additives in chill stored raw lamb patties. Meat Sci. 2017;1;129:62-70. https://doi.org/10.1016/j.meatsci.2017.02.013
4. Rahimi HR, Arastoo M, Ostad SN. A comprehensive review of Punica granatum (pomegranate) properties in toxicological, pharmacological, cellular and molecular biology researches. Iran J Pharm Res.2012;11(2):385.
5. Stover ED, Mercure EW. The pomegranate: a new look at the fruit of paradise. Hort Science. 2007;1;42(5):1088-92. https://doi.org/10.21273/HORTSCI.42.5.1088
6. Dahlgren R, Thorne RF. The order Myrtales: circumscription, variation, and relationships. Ann Mo Bot Gard. 1984 Jan 1:633-99. https://doi.org/10.2307/2399158
7. Jurenka J. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev. 2008;1;13(2).
8. Naqvi S, Khan MS, Vohora SB. Anti-bacterial, anti-fungal and anthelmintic investigations on Indian medicinal plants. Fitoterapia. 1991;62(3):221-8.
9. Cáceres A, Girón LM, Alvarado SR, Torres MF. Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases. J Ethnopharmacol. 1987;1;20(3):223-37. https://doi.org/10.1016/0378-8741(87)90050-X
10. Lad V, Frawley D. The Yoga of Herbs. Santa Fe. 1986;135-36.
11. Saxena A, Vikram NK. Role of selected Indian plants in management of type 2 diabetes: a review. J. Altern. Complementary Med. 2004;1;10(2):369-78. https://doi.org/10.1089/107555304323062365
12. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;19;109(2):177-206. https://doi.org/10.1016/j.jep.2006.09.006
13. Derakhshan Z, Ferrante M, Tadi M, Ansari F, Heydari A, Hosseini MS, et al. Antioxidant activity and total phenolic content of ethanolic extract of pomegranate peels, juice and seeds. Food Chem Toxicol. 2018;1;114:108-11.https://doi.org/10.1016/j.fct.2018.02.023
14. Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food chem. 2006; 1;96(2):254-60. https://doi.org/10.1016/j.foodchem.2005.02.033
15. Mandal A, Bhatia D, Bishayee A. Anti-inflammatory mechanism involved in pomegranate-mediated prevention of breast cancer: The role of NF-?B and Nrf2 signaling pathways. Nutrients. 2017;9(5):436. https://doi.org/10.3390/nu9050436
16. Rouhi SZ, Sarker MM, Rahmat A, Alkahtani SA, Othman F. The effect of pomegranate fresh juice versus pomegranate seed powder on metabolic indices, lipid profile, inflammatory biomarkers, and the histopathology of pancreatic islets of Langerhans in streptozotocin-nicotinamide induced type 2 diabetic Sprague–Dawley rats. BMC Complement Altern Med. 2017;17(1):156. https://doi.org/10.1186/s12906-017-1724-1
17. Braidy N, Selvaraju S, Essa MM, Vaishnav R, Al-Adawi S, Al-Asmi A, et al. Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons. Oxid Med Cell Longev. 2013;3;2013. https://doi.org/10.1155/2013/685909
18. Rahmani AH, Alsahli MA, Almatroodi SA. Active constituents of pomegranates (Punica granatum) as potential candidates in the management of health through modulation of biological activities. PhcogJ. 2017;9(5). https://doi.org/10.5530/pj.2017.5.109
19. Moghaddam G, Sharifzadeh M, Hassanzadeh G, Khanavi M, Hajimahmoodi M. Anti-ulcerogenic activity of the pomegranate peel (Punica granatum) methanol extract. Food Nutr Sci. 2013; 12;4(10):43. https://doi.org/10.4236/fns.2013.410A008
20. Amri Z, Ghorbel A, Turki M, Akrout FM, Ayadi F, Elfeki A, Hammami M. Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model. BMC Complement Altern Med. 2017;17(1):339. https://doi.org/10.1186/s12906-017-1842-9
21. Razani Z, Dastani M, Kazerani HR. Cardioprotective effects of pomegranate (Punica granatum) juice in patients with ischemic heart disease. Phytother Res. 2017;31(11):1731-8. https://doi.org/10.1002/ptr.5901
22. Forest CP, Padma-Nathan H, Liker HR. Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study. Int J Impot Res. 2007;19(6):564. https://doi.org/10.1038/sj.ijir.3901570
23. Rahmani AH, Alsahli MA, Almatroodi SA. Active constituents of pomegranates (Punica granatum) as potential candidates in the management of health through modulation of biological activities. PhcogJ. 2017;9(5). https://doi.org/10.5530/pj.2017.5.109
24. Sastravaha G, Gassmann G, Sangtherapitikul P, Grimm WD. Adjunctive periodontal treatment with Centella asiatica and Punica granatum extracts in supportive periodontal therapy. J Int Acad Periodontol. 2005;7(3):70-79.
25. Kim YH, Choi EM. Stimulation of osteoblastic differentiation and inhibition of interleukin?6 and nitric oxide in MC3T3?E1 cells by pomegranate ethanol extract. Phytother Res. 2009;23(5):737-39. https://doi.org/10.1002/ptr.2587
26. Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 2006;1;24(3):506-15. https://doi.org/10.1016/j.nbd.2006.08.006
27. Afaq F, Zaid MA, Khan N, Dreher M, Mukhtar H. Protective effect of pomegranate?derived products on UVB?mediated damage in human reconstituted skin. Exp Dermatol. 2009;18(6):553-61. https://doi.org/10.1111/j.1600-0625.2008.00829.x
28. Sreekumar S, Sithul H, Muraleedharan P, Azeez JM, Sreeharshan S. Pomegranate fruit as a rich source of biologically active compounds. BioMed Res. Int. 2014. https://doi.org/10.1155/2014/686921
29. Viuda?Martos M, Fernández?López J, Pérez?Álvarez JA. Pomegranate and its many functional components as related to human health: a review. Compr Rev Food Sci Food Saf. 2010;9(6):635-54. https://doi.org/10.1111/j.1541-4337.2010.00131.x
30. Hernandez F, Melgarejo P, Tomas-Barberan FA, Artes F. Evolution of juice anthocyanins during ripening of new selected pomegranate (Punica granatum) clones. Eur Food Res Technol. 1999;1;210(1):39-42. https://doi.org/10.1007/s002170050529
31. Nasr CB, Ayed N, Metche M. Quantitative determination of the polyphenolic content of pomegranate peel. Eur Food Res Technol. 1996;1;203(4):374-8. https://doi.org/10.1007/BF01231077
32. Singh B, Singh JP, Kaur A, Singh N. Phenolic compounds as beneficial phytochemicals in pomegranate (Punica granatum L.) peel: A review. Food chem. 2018; 30;261:75-86. https://doi.org/10.1016/j.foodchem.2018.04.039
33. Kalayc?o?lu Z, Erim FB. Total phenolic contents, antioxidant activities, and bioactive ingredients of juices from pomegranate cultivars worldwide. Food chem. 2017; 15;221:496-507. https://doi.org/10.1016/j.foodchem.2016.10.084
34. Fadavi A, Barzegar M, Azizi MH. Determination of fatty acids and total lipid content in oilseed of 25 pomegranates varieties grown in Iran.
J Food Compost Anal. 2006;1;19(6-7):676-80. https://doi.org/10.1016/j.jfca.2004.09.002
35. Du CT, Wang PL, Francis FJ. Anthocyanins of pomegranate, Punica granatum. J. Food Sci. 1975;40(2):417-18. https://doi.org/10.1111/j.1365-2621.1975.tb02217.x
36. http://www.nutritiondata.com/facts-C00001-01c20Ws.html. Nutrition data for pomegranate [accessed May 2015].
37. Amakura Y, Okada M, Tsuji S, Tonogai Y. Determination of phenolic acids in fruit juices by isocratic column liquid chromatography. J Chromatogr A. 2000; 1;891(1):183-8. https://doi.org/10.1016/S0021-9673(00)00625-7
38. de Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J Agric Food Chem. 2000; 20;48(11):5331-7. https://doi.org/10.1021/jf000549h
39. Artik N. Determination of phenolic compounds in pomegranate juice by using HPLC. Fruit Processing. 1998;8:492-9.
40. Waheed S, Siddique N, Rahman A, Zaidi JH, Ahmad S. INAA for dietary assessment of essential and other trace elements in fourteen fruits harvested and consumed in Pakistan. J Radioanal Nucl Chem. 2004;1;260(3):523-31. https://doi.org/10.1023/B:JRNC.0000028211.23625.99
41. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. Journal J Ethnopharmacol. 1999;1;66(1):11-7. https://doi.org/10.1016/S0378-8741(98)00222-0
42. Abd El Wahab SM, El Fiki NM, Mostafa SF, et al. Characterization of certain steroid hormones in Punica granatum L. seeds. Bull Fac Pharm 1998;36:11-15.
43. Tanaka T, Nonaka GI, Nishioka I. Tannins and Related Compounds. XL.: Revision of the Structures of Punicalin and Punicalagin, and Isolation and Characterization of 2-O-Galloylpunicalin from the Bark of Punica granatum L. Chem Pharm Bull. 1986;25;34(2):650-55. https://doi.org/10.1248/cpb.34.650
44. Nawwar MA, Hussein SA, Merfort I. NMR spectral analysis of polyphenols from Punicagranatum.Phytochemistry. 1994;1;36(3):793-98. https://doi.org/10.1016/S0031-9422(00)89820-9
45. Noda Y, Kaneyuki T, Mori A, Packer L. Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric Food Chem. 2002; 2;50(1):166-71. https://doi.org/10.1021/jf0108765
46. Huang TH, Yang Q, Harada M, Li GQ, Yamahara J, Roufogalis BD, et al. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J Cardiovasc Pharmacol.2005;1;46(6):856-62. https://doi.org/10.1097/01.fjc.0000190489.85058.7e
47. Batta AK, Rangaswami S. Crystalline chemical components of some vegetable drugs. Phytochemistry. 1973.
48. Neuhöfer H, Witte L, Gorunovic M, Czygan FC. Alkaloids in the bark of Punica granatum L. (pomegranate) from Yugoslavia. Pharmazie. 1993;48(5):389-91.
49. Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G. Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Eur Urol. 2005; 1;47(4):449-55. https://doi.org/10.1016/j.eururo.2004.12.001
50. Hassoun EA, Vodhanel J, Abushaban A. The modulatory effects of ellagic acid and vitamin E succinate on TCDD?induced oxidative stress in different brain regions of rats after subchronic exposure. J Biochem Mol Toxicol. 2004;18(4):196-203. https://doi.org/10.1002/jbt.20030
51. Mertens-Talcott SU, Bomser JA, Romero C, Talcott ST, Percival SS. Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr. 2005; 1;135(3):609-14. https://doi.org/10.1093/jn/135.3.609
52. Mertens-Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 2005;10;218(2):141-51. https://doi.org/10.1016/j.canlet.2004.06.007
53. Lansky EP, Jiang W, Mo H, Bravo L, Froom P, Yu W, et al. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs.2005;1;23(1):11-20. https://doi.org/10.1023/B:DRUG.0000047101.02178.07
54. Lansky EP, Harrison G, Froom P, Jiang WG. Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel™. Invest New Drugs. 2005;1;23(2):121-2. https://doi.org/10.1007/s10637-005-5856-7
55. Seeram NP, Lee R, Heber D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta. 2004; 1;348(1-2):63-8. https://doi.org/10.1016/j.cccn.2004.04.029
56. Cerdá B, Espín JC, Parra S, Martínez P, Tomás-Barberán FA. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6–one derivatives by the colonic microflora of healthy humans. Eur J Nutr. 2004;1;43(4):205-20. https://doi.org/10.1007/s00394-004-0461-7
57. Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci. 2005;13;102(37):13254-9. https://doi.org/10.1073/pnas.0504830102
58. Wekerle H. Brain autoimmunity and intestinal microbiota: 100 trillion game changers. Trends Immunol. 2017;1;38(7):483-97.https://doi.org/10.1016/j.it.2017.03.008
59. Gibson GR. Prebiotics as gut microflora management tools. J Clin Gastroenterol.2008;1;42:S75-9. https://doi.org/10.1097/MCG.0b013e31815ed097
60. Rastall RA, Gibson GR, Gill HS, Guarner F, Klaenhammer TR, Pot B, et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications.FEMS MicrobiolEcol.2005;1;52(2):145-52. https://doi.org/10.1016/j.femsec.2005.01.003
61. Bialonska D, Ramnani P, Kasimsetty SG, Muntha KR, Gibson GR, Ferreira D. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int J Food Microbiol. 2010; 15;140(2-3):175-82. https://doi.org/10.1016/j.ijfoodmicro.2010.03.038
62. Bialonska D, Kasimsetty SG, Schrader KK, Ferreira D. The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria.JAgric Food Chem.2009;25;57(18):8344-9. https://doi.org/10.1021/jf901931b
63. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;1;20(5):649-88. https://doi.org/10.1210/edrv.20.5.0380
64. Han L, Shen WJ, Bittner S, Kraemer FB, Azhar S. PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-?. Future Cardiol. 2017;13(3):259-78. https://doi.org/10.2217/fca-2016-0059
65. Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, et al. A novel PPAR? gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology. 2003;1;124(5):1315-24. https://doi.org/10.1016/S0016-5085(03)00262-2
66. Ogata T, Miyauchi T, Sakai S, Irukayama-Tomobe Y, Katsutoshi GO, Yamaguchi I. Stimulation of peroxisome-proliferator-activated receptor ? (PPAR ?) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts. Clin Sci (Lond). 2002:284S-288S. https://doi.org/10.1042/CS103S284S
67. Hsu SC, Huang CJ. Changes in liver PPAR? mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice. J Nutr Biochem. 2007;1;18(2):86-96. https://doi.org/10.1016/j.jnutbio.2006.03.003
68. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, et al. PPAR-? and PPAR-? activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature medicine. 2001;7(1):53. https://doi.org/10.1038/83348
69. Bassaganya-Riera J, Guri AJ, Hontecillas R. Treatment of obesity-related complications with novel classes of naturally occurring PPAR agonists. J obes. 2010;28;2011. https://doi.org/10.1155/2011/897894
70. Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, et al. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008;1;134(3):688-95. https://doi.org/10.1053/j.gastro.2007.12.012
71. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes care. 2004; 1;27(1):256-63. https://doi.org/10.2337/diacare.27.1.256
72. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.JAgric Food Chem.2000;16;48(10):4581-9. https://doi.org/10.1021/jf000404a
73. Rosenblat M, Volkova N, Coleman R, Aviram M. Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein. Journal J Agric Food Chem. 2006;8;54(5):1928-35. https://doi.org/10.1021/jf0528207
74. Guo C, Wei J, Yang J, Xu J, Pang W, Jiang Y. Pomegranate juice is potentially better than apple juice in improving antioxidant function in elderly subjects. Nutr Res. 2008;1;28(2):72-77. https://doi.org/10.1016/j.nutres.2007.12.001
75. Schubert SY, Lansky EP, Neeman I. Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol. 1999; 1;66(1):11-17. https://doi.org/10.1016/S0378-8741(98)00222-0
76. Chidambara Murthy KN, Jayaprakasha GK, Singh RP. Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models. Journal J Agric Food Chem. 2002; 14;50(17):4791-95. https://doi.org/10.1021/jf0255735
77. Viladomiu M, Hontecillas R, Lu P, Bassaganya-Riera J. Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evid Based Complement Alternat Med. 2013.. https://doi.org/10.1155/2013/789764
78. Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM, Patel A, et al. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food. 2004;1;7(3):274-83. https://doi.org/10.1089/jmf.2004.7.274
79. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci. 2005; 11;102(41):14813-18. https://doi.org/10.1073/pnas.0505870102
80. Sheu ML, Chao KF, Sung YJ, Lin WW, Lin-Shiau SY, Liu SH. Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cell Signal. 2005;1;17(8):975-84. https://doi.org/10.1016/j.cellsig.2004.11.015
81. Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, et al. Regulation of Cyclooxygenase-2 by Interferon ? and Transforming Growth Factor ? in Normal Human Epidermal Keratinocytes and Squamous Carcinoma Cells Role of mitogen-activated protein kinases. J. Biol. Chem. 1999;8;274(41):29138-48. https://doi.org/10.1074/jbc.274.41.29138
82. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007; 19;109(2):177-206. https://doi.org/10.1016/j.jep.2006.09.006
83. Okamoto T, Akuta T, Tamura F, van Der Vliet A, Akaike T. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol chem. 2004;1;385(11):997-1006. https://doi.org/10.1515/BC.2004.130
84. Heber D. Multitargeted therapy of cancer by ellagitannins. Cancer lett. 2008; 8;269(2):262-8. https://doi.org/10.1016/j.canlet.2008.03.043
85. Conner EM, Grisham MB, “Inflammation, free radicals and antioxidants,” Nutrition, 1996;12(4): 274–7. https://doi.org/10.1016/S0899-9007(96)00000-8
86. Larrosa M, González-Sarrías A, Yáñez-Gascón MJ, Selma MV, Azorín-Ortuño M, Toti S, et al. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.JNutrBiochem.2010;1;21(8):717-25. https://doi.org/10.1016/j.jnutbio.2009.04.012
87. Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T, “Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats,” Cancer Sci. 2004;95(6):481-6. https://doi.org/10.1111/j.1349-7006.2004.tb03236.x
88. Pantuck AJ, Leppert JT, Zomorodian N, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin. Cancer Res. 2006;12:4018-26. https://doi.org/10.1158/1078-0432.CCR-05-2290
89. Lansky EP, inventor; Lansky, Ephraim Philip, assignee. Phytoestrogen supplements prepared from pomegranate material including pomegranate seeds. United States patent US 6,060,063. 2000..
90. Lansky EP, inventor; Lansky, Ephraim Philip, assignee. Phytoestrogen supplement prepared from pomegranate seeds and a herbal mixture or coconut milk. United States patent US 5,891,440. 1999.
Downloads
Published
01-01-2020
How to Cite
1.
Puneeth HR, Chandra SSP. A review on potential therapeutic properties of Pomegranate (Punica granatum L.). Plant Sci. Today [Internet]. 2020 Jan. 1 [cited 2024 Dec. 22];7(1):9-16. Available from: https://horizonepublishing.com/journals/index.php/PST/article/view/619
Issue
Section
Review Articles
License
Copyright and Licence details of published articles
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Open Access Policy
Plant Science Today is an open access journal. There is no registration required to read any article. All published articles are distributed under the terms of the Creative Commons Attribution License (CC Attribution 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
